Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lannett announced it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP.
read more
Thursday, October 05, 2023
Bend Bioscience, a provider of drug delivery innovation, development and manufacturing services, announced the opening of its state-of-the-art Pharmaceutical Process and Manufacturing Science Facility.
read more
A survey of biopharmaceutical dealmakers by Campbell Alliance, the consulting firm of inVentiv Health, suggests that 2015 will set a new record for mergers and acquisitions and licensing of biopharmaceutical assets.
read more
Biomica has entered a service agreement with Biose Industrie for the scale-up production of its drug candidates, microbial consortia BMC121 & BMC127 for its Immuno-Oncology program.
read more
SGS has introduced comprehensive drug compatibility study testing at its Shanghai laboratory in China. This new service, for the analysis of potential extractable and leachable contamination within pharmaceutical products, harmonizes services offered...
read more
Thursday, August 09, 2018
Perrigo has entered into a licensing agreement with a subsidiary of Merck for the exclusive rights in the United States to pursue regulatory approval for an OTC Nasonex Nasal Spray.
read more
Thursday, August 29, 2019
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.
read more
Wednesday, April 06, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced the company has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500m³ of batch capacity to meet demands for upcoming commercialization ...
read more
Tuesday, January 10, 2023
Ajinomoto Co., Inc. announced a license agreement with Exelixis, Inc. to incorporate AJICAP®, Ajinomoto Co.’s proprietary site-specific bioconjugation and linker technologies, in the development of certain of Exelixis’ antibody-drug conjugate (ADC) ...
read more
Wednesday, April 28, 2021
AavantiBio and Catalent have announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies.
read more
SGD Pharma’s 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format. Increased demand for parenteral drugs generated by the Covid-19 ...
read more
Tuesday, December 10, 2024
Matica Biotechnology has announced a strategic partnerships with Treovir that aims to advance innovative therapies for pediatric patients with brain and other neurological cancers. Matica Bio will provide GMP manufacturing for clinical supplies.
read more
BioLife Solutions announced a $1 million equity investment in SAVSU Technologies, a designer and manufacturer of high-performance cloud-connected storage and transport containers optimized for the cell and gene therapy supply chain.
read more
Taconic Biosciences announced local West Coast United States production of the immunodeficient CIEA NOG mouse® model.
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Vaccibody AS, a biotechnology company developing the next generation of vaccines against cancer and chronic infections, today announce an...
read more